Literature DB >> 9827293

Demyelinating polyneuropathy associated with human granulocytic ehrlichiosis.

J S Bakken1, S A Erlemeyer, R J Kanoff, T C Silvestrini, D D Goodwin, J S Dumler.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9827293

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  5 in total

Review 1.  Human granulocytic anaplasmosis.

Authors:  Johan S Bakken; J Stephen Dumler
Journal:  Infect Dis Clin North Am       Date:  2015-06       Impact factor: 5.982

2.  Exploitation of interleukin-8-induced neutrophil chemotaxis by the agent of human granulocytic ehrlichiosis.

Authors:  M Akkoyunlu; S E Malawista; J Anguita; E Fikrig
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

3.  Gamma interferon dominates the murine cytokine response to the agent of human granulocytic ehrlichiosis and helps to control the degree of early rickettsemia.

Authors:  M Akkoyunlu; E Fikrig
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

4.  Ehrlichia infection of the central nervous system.

Authors:  Igen Hongo; Karen C Bloch
Journal:  Curr Treat Options Neurol       Date:  2006-05       Impact factor: 3.972

Review 5.  Non-lyme tick-borne diseases: a neurological perspective.

Authors:  Navid Seraji-Bozorgzad; Alexandros C Tselis
Journal:  Curr Neurol Neurosci Rep       Date:  2013-10       Impact factor: 6.030

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.